Advertisements



Iovance Biotherapeutics reports results from FDA end of Phase 2 meeting

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 11th, 2018

Cerus reports results of SPARC Phase 3 study at EHA meeting

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 15th, 2018

Loxo Oncology Reports First Quarter 2018 Financial Results

- LOXO-292 Phase 1 Oral Presentation Upcoming at 2018 ASCO Annual Meeting - - LOXO-292 Preclinical and Cl.....»»

Category: earningsSource: benzingaMay 8th, 2018

Exelixis reports Phase 1b results of cabozantinib combination in carcinoma

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 22nd, 2018

Deciphera reports preliminary results of Phase 1 clinical study of DCC-2618

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 19th, 2018

Eiger BioPharmaceuticals reports Phase 2 results of HDV infection candidate

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 17th, 2018

Auris Medical reports Phase 1 clinical trial results for intranasal betahistine

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 17th, 2018

Eiger BioPharmaceuticals reports results from Phase 2 ULTRA study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 16th, 2018

Sanofi reports results from two Phase 3 trials evaluating Dupixent

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 16th, 2018

Mid-Day Market Update: EXFO Falls After Q4 Results; Iovance Biotherapeutics Shares Climb

Midway through trading Friday, the Dow traded up 0.80 percent to 25,252.55 while the NASDAQ climbed 1.82 percent to 7,462.44. The S&P also rose, gaining 1.14 percent to 2,759.37. read more.....»»

Category: blogSource: benzingaOct 12th, 2018

WSI Industries Reports Preliminary Fourth Quarter and Fiscal Year 2018 Results; Declares Quarterly Dividend and Provides Update On Special Meeting

MINNEAPOLIS, Oct. 04, 20.....»»

Category: earningsSource: benzingaOct 4th, 2018

Alnylam reports updated "positive" results from Phase 1/2 study of lumasiran

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 4th, 2018

ObsEva reports additional "positive" Phase 3 results of IMPLANT 2 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 3rd, 2018

Arena Pharmaceuticals reports "positive" Phase 2a results for olorinab

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 24th, 2018

AMREP Reports First Quarter Fiscal 2019 Results

PLYMOUTH MEETING, Pa., Sept. 11, 2018 (GLOBE NEWSWIRE) -- AMREP Corporation (NYSE:AXR) today rep.....»»

Category: earningsSource: benzingaSep 11th, 2018

ERYTECH Reports First Half of 2018 Financial Results and Provides Business Update

Conference call and webcast scheduled for Tuesday, September 11that 2:30 pm CET/8:30 am EDT Strategic shift to development of eryaspase for solid tumors confirmed Phase 3 trial for eryaspase in second line pan.....»»

Category: earningsSource: benzingaSep 10th, 2018

AbbVie Posts Positive Data on Elagolix for Uterine Fibroids

AbbVie (ABBV) reports positive top-line results from a phase III extension trial on its investigational candidate Elagolix for .....»»

Category: personnelSource: nytAug 23rd, 2018

Neuralstem Provides Business Update and Reports Second Quarter 2018 Fiscal Results

- Phase 2 clinical trial initi.....»»

Category: earningsSource: benzingaAug 15th, 2018

Realm Therapeutics Reports Top-line Data from Phase 2 Trial of PR022 in Atopic Dermatitis and First Half 2018 Financial Results

Realm Therapeutics Reports Top-line Data from Phase 2 Trial of PR022 in Atopic Dermatitis and First Half 2018 Financial R.....»»

Category: earningsSource: benzingaAug 14th, 2018

Avenue Therapeutics Reports Second Quarter 2018 Financial Results and Recent Corporate Highlights

Company reported positive Phase 3 data in patients wit.....»»

Category: earningsSource: benzingaAug 14th, 2018

Diffusion Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Business Update

Enrollment continues in Phase 3 GBM brain cancer trial Key European patent validated covering oral formulation of TSC Preparing for Phase 2 stroke trial with in-am.....»»

Category: earningsSource: benzingaAug 13th, 2018